Integrative analyses prioritize GNL3 as a risk gene for bipolar disorder

Aug 23, 2020Molecular psychiatry

Combined analyses highlight GNL3 as a gene linked to bipolar disorder risk

AI simplified

Abstract

Variants rs10865973, rs12635140, and rs4687644 may regulate the expression of the protein-coding gene G Protein Nucleolar 3 (GNL3) associated with bipolar disorder (BD).

  • Convergent evidence suggests GNL3 is a risk gene for BD.
  • GNL3 is implicated in cell proliferation and neuronal functions.
  • Knockdown and overexpression of GNL3 resulted in abnormal neuronal proliferation and differentiation.
  • Integrative analyses linked BD-related genetic variants to changes in GNL3 expression.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free